Equifax to Provide Gemalto Security Solution to U.S. Healthcare Providers
First Implementation with HEALTHeLINK, the Clinical Information Exchange for Buffalo, NY and Surrounding Region
Regulatory News:
Gemalto, the world leader in digital security, today announced it will provide multi-factor authentication one-time password (OTP) tokens to Equifax, a leader in identity management. The security devices, based on Open Authentication (OATH), are part of Gemalto’s Protiva Medsecure solution and will be packaged within Equifax’s Anakam Identity Services. The Gemalto solution will extend the existing Equifax offer, adding a comprehensive, secure platform which allows flexibility in authenticating users with diverse compliance and security requirements – such as financial services, government solutions, and healthcare – while ensuring information is kept private and confidential.
The first implementation of this system is for HEALTHeLINK, a collaboration structure among healthcare providers in an eight county region of western New York State that includes Buffalo and Niagara Falls, to securely share medical and clinical information electronically. The Gemalto Protiva Medsecure strong authentication solution is in particular able to accommodate situations in which users are unable to receive their one-time passwords through text messaging or interactive voice response. Physicians often face network coverage problems in hospitals and are thus unable to utilize a mobile device.
“The solution offers our physicians a highly secure method to access electronic health records even in locations where hospital or clinic policies forbid cell phones for text message delivery or mobile applications ,” said Dan Porreca, Executive Director of HEALTHeLINK. “We have used authentication technology successfully for several years and this addition allows us to more fully meet the requirements for secure access to patient records and offers flexibility in how we manage that security .”
“The Equifax Anakam Identity Services offers HEALTHeLINK a comprehensive and secure platform to grant physicians and other providers online access to electronic patient records,” said Garry Capers, VP Business Development, Equifax. “Adding Gemalto’s expertise in identity management strengthens our existing offering and helps HEALTHeLINK meet applicable federal and state standards for security in healthcare IT.”
“The implementation of multi-factor authentication by HEALTHeLINK provides better security and privacy of medical records,” said Tom Flynn, Vice-President Online Authentication at Gemalto North America. “Gemalto‘s versatile authentication solution easily complements Equifax’s flexible platform of risk-based identity management. It also provides a path for Equifax to grow its authentication practice as its customer needs evolve.”
More information about HEALTHeLINK services can be found at http://wnyhealthelink.com/ .
About Gemalto
Gemalto (Euronext NL0000400653 GTO) is the world leader in digital security with 2011 annual revenues of €2 billion and more than 10,000 employees operating out of 74 offices and 14 Research & Development centers, located in 43 countries.
We are at the heart of the rapidly evolving digital society. Billions of people worldwide increasingly want the freedom to communicate, travel, shop, bank, entertain and work – anytime, everywhere – in ways that are enjoyable and safe. Gemalto delivers on their expanding needs for personal mobile services, payment security, authenticated cloud access, identity and privacy protection, eHealthcare and eGovernment efficiency, convenient ticketing and dependable machine-to-machine (M2M) applications.
Gemalto develops secure embedded software and secure products which we design and personalize. Our platforms and services manage these secure products, the confidential data they contain and the trusted end-user services they enable. Our innovations offer more ways for our clients to enhance the convenience and security of people’s digital lives.
Gemalto thrives with the growing number of people using its solutions to interact with the digital and wireless world.
For more information visit www.gemalto.com , www.justaskgemalto.com , blog.gemalto.com , or follow @gemalto on Twitter.
About HEALTHeLINK:
The not-for-profit organization was
established through funding from BlueCross BlueShield of Western New
York, The Catholic Health System, Erie County Medical Center
Corporation, Independent Health Association, Kaleida Health, Roswell
Park Cancer Institute, Univera Healthcare and the Health Care Efficiency
and Affordability Law for New Yorkers Capital Grant Program (HEAL NY)
from New York State. HEALTHeLINK also received one of the country’s
largest awards as part of the United States Department of Health and
Human Services’ Beacon Community Cooperative Agreement Program.
HEALTHeLINK stakeholders include a broad representation of healthcare professionals and organizations throughout the eight-county Western New York region such as the State University of New York at Buffalo, P2 Collaborative, Chautauqua County Health Network, the WNY Rural Area Health Education Center and local county public health departments. For more information on HEALTHeLINK, visit www.wnyhealthelink.com .
Contact:
Gemalto Media Contacts:
Nicole Smith
North America
+1
512 257 3902
nicole.smith@gemalto.com
or
Ernesto
Haikewitsch
Latin America
+55 11 51 05 92 20
ernesto.haikewitsch@gemalto.com
or
Yvonne
Lim
Asia Pacific
+65 6317 3730
yvonne.lim@gemalto.com
or
Kristel
Teyras
Europe, Middle East & Africa
+33 1 55 01 57 89
kristel.teyras@gemalto.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom